Dr. Abhishek Solanki, M.D

NPI: 1760612808
Total Payments
$49,123
2023 Payments
$25,176
Companies
10
Transactions
51
Medicare Patients
2,350
Medicare Billing
$400,682

Payment Breakdown by Category

Research$18,900 (38.5%)
Consulting$14,769 (30.1%)
Other$10,599 (21.6%)
Travel$3,359 (6.8%)
Food & Beverage$1,497 (3.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $18,900 4 38.5%
Consulting Fee $14,769 7 30.1%
Honoraria $10,599 5 21.6%
Travel and Lodging $3,359 19 6.8%
Food and Beverage $1,497 16 3.0%

Payments by Type

General
$30,223
47 transactions
Research
$18,900
4 transactions

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $24,037 12 $0 (2023)
Novocure Inc. $9,491 15 $0 (2019)
Blue Earth Diagnostics Limited $7,485 8 $0 (2020)
Varian Medical Systems, Inc. $3,375 8 $0 (2019)
GE HealthCare $3,270 2 $0 (2022)
Bard Peripheral Vascular, Inc. $999.00 2 $0 (2023)
Elekta, Inc. $139.52 1 $0 (2023)
Dendreon Pharmaceuticals LLC $129.49 1 $0 (2017)
Janssen Biotech, Inc. $102.79 1 $0 (2019)
Augmenix, Inc. $93.82 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $25,176 15 PFIZER INC. ($24,037)
2022 $3,270 2 GE HealthCare ($3,270)
2020 $75.00 1 Blue Earth Diagnostics Limited ($75.00)
2019 $12,969 24 Novocure Inc. ($9,491)
2018 $1,366 4 Blue Earth Diagnostics Limited ($1,272)
2017 $6,268 5 Blue Earth Diagnostics Limited ($6,138)

All Payment Transactions

51 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/30/2023 PFIZER INC. XTANDI (Drug) Cash or cash equivalent $1,150.00 Research
Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY
10/25/2023 PFIZER INC. XTANDI (Drug) Cash or cash equivalent $10,250.00 Research
Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY
10/25/2023 PFIZER INC. XTANDI (Drug) Cash or cash equivalent $4,000.00 Research
Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY
10/25/2023 PFIZER INC. XTANDI (Drug) Cash or cash equivalent $3,500.00 Research
Study: A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES • Category: ONCOLOGY
10/06/2023 PFIZER INC. ORGOVYX (Drug) Consulting Fee Cash or cash equivalent $4,410.00 General
Category: ONCOLOGY
10/03/2023 Elekta, Inc. ELEKTA MEDICAL LINEAR ACCELERATOR (Device) Food and Beverage In-kind items and services $139.52 General
Category: LINAC SOLUTIONS (LINAC)
10/02/2023 Bard Peripheral Vascular, Inc. Honoraria Cash or cash equivalent $599.00 General
10/01/2023 PFIZER INC. Food and Beverage In-kind items and services $118.40 General
08/16/2023 PFIZER INC. ORGOVYX (Drug) Travel and Lodging Cash or cash equivalent $99.98 General
Category: ONCOLOGY
07/21/2023 PFIZER INC. ORGOVYX (Drug) Travel and Lodging In-kind items and services $254.81 General
Category: ONCOLOGY
07/21/2023 PFIZER INC. ORGOVYX (Drug) Travel and Lodging In-kind items and services $168.98 General
Category: ONCOLOGY
07/21/2023 PFIZER INC. ORGOVYX (Drug) Food and Beverage In-kind items and services $35.08 General
Category: ONCOLOGY
07/21/2023 PFIZER INC. ORGOVYX (Drug) Travel and Lodging In-kind items and services $25.00 General
Category: ONCOLOGY
07/21/2023 PFIZER INC. ORGOVYX (Drug) Travel and Lodging In-kind items and services $25.00 General
Category: ONCOLOGY
04/28/2023 Bard Peripheral Vascular, Inc. Honoraria Cash or cash equivalent $400.00 General
09/02/2022 GE HealthCare Consulting Fee Cash or cash equivalent $3,234.00 General
09/02/2022 GE HealthCare Travel and Lodging Cash or cash equivalent $36.00 General
04/09/2020 Blue Earth Diagnostics Limited Axumin (Drug) Consulting Fee Cash or cash equivalent $75.00 General
Category: Diagnostic Imaging
11/07/2019 Novocure Inc. Oncology (Device) Travel and Lodging Cash or cash equivalent $44.92 General
Category: Optune
11/07/2019 Novocure Inc. Oncology (Device) Food and Beverage Cash or cash equivalent $27.96 General
Category: Optune
11/03/2019 Varian Medical Systems, Inc. Edge (Device) Travel and Lodging In-kind items and services $94.00 General
Category: Devices
11/03/2019 Varian Medical Systems, Inc. Edge (Device) Travel and Lodging In-kind items and services $24.09 General
Category: Devices
11/02/2019 Varian Medical Systems, Inc. Edge (Device) Honoraria Cash or cash equivalent $2,000.00 General
Category: Devices
11/02/2019 Varian Medical Systems, Inc. Edge (Device) Travel and Lodging In-kind items and services $356.01 General
Category: Devices
11/02/2019 Varian Medical Systems, Inc. Edge (Device) Food and Beverage In-kind items and services $5.20 General
Category: Devices

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES PFIZER INC. $18,900 4

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 645 1,559 $761,038 $123,491
2022 14 531 1,108 $490,030 $77,916
2021 17 743 1,753 $778,096 $130,815
2020 14 431 916 $409,908 $68,460
Total Patients
2,350
Total Services
5,336
Medicare Billing
$400,682
Procedure Codes
64

All Medicare Procedures & Services

64 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
77427 Radiation treatment management, 5 treatment sessions Facility 2023 42 153 $224,910 $24,215 10.8%
77014 Ct guidance for insertion of radiation therapy fields Facility 2023 66 647 $119,695 $23,126 19.3%
55875 Insertion of needle or tube into prostate for radiation therapy Facility 2023 11 19 $49,608 $12,480 25.2%
77301 High precision radiation therapy planning Facility 2023 31 32 $55,392 $11,061 20.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 75 75 $57,123 $10,392 18.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 91 122 $50,934 $8,587 16.9%
77263 Complex radiation therapy planning Facility 2023 51 52 $65,879 $7,375 11.2%
77338 Design and construction of radiation treatment device for high precision radiation therapy Facility 2023 31 33 $30,657 $6,122 20.0%
77300 Calculation of radiation therapy dose Facility 2023 39 133 $18,900 $3,654 19.3%
77334 Design and construction of complex radiation treatment device Facility 2023 42 75 $19,250 $3,603 18.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 28 32 $19,451 $3,575 18.4%
77295 3d radiation therapy planning Facility 2023 12 12 $11,148 $2,226 20.0%
77290 Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved Facility 2023 25 31 $10,478 $2,106 20.1%
77470 Special radiation treatment Facility 2023 20 20 $8,800 $1,768 20.1%
76965 Ultrasonic guidance for administration of radiation therapy Facility 2023 11 19 $5,529 $1,035 18.7%
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy Facility 2023 23 51 $4,284 $763.65 17.8%
77332 Design and construction of simple radiation treatment device Facility 2023 25 31 $3,038 $590.70 19.4%
55876 Placement of device in prostate for radiation therapy Facility 2023 11 11 $4,356 $557.86 12.8%
76942 Ultrasonic guidance for needle placement Facility 2023 11 11 $1,606 $255.34 15.9%
77427 Radiation treatment management, 5 treatment sessions Facility 2022 28 80 $121,047 $12,089 10.0%
77014 Ct guidance for insertion of radiation therapy fields Facility 2022 57 319 $59,015 $11,318 19.2%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 74 74 $56,092 $10,030 17.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 96 136 $56,576 $9,565 16.9%
77301 High precision radiation therapy planning Facility 2022 22 22 $38,082 $7,647 20.1%
77263 Complex radiation therapy planning Facility 2022 37 37 $46,805 $5,209 11.1%

About Dr. Abhishek Solanki, M.D

Dr. Abhishek Solanki, M.D is a Radiation Oncology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1760612808.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abhishek Solanki, M.D has received a total of $49,123 in payments from pharmaceutical and medical device companies, with $25,176 received in 2023. These payments were reported across 51 transactions from 10 companies. The most common payment nature is "" ($18,900).

As a Medicare-enrolled provider, Solanki has provided services to 2,350 Medicare beneficiaries, totaling 5,336 services with total Medicare billing of $400,682. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.

Practice Information

  • Specialty Radiation Oncology
  • Location Maywood, IL
  • Active Since 07/23/2009
  • Last Updated 04/23/2021
  • Taxonomy Code 2085R0001X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1760612808

Products in Payments

  • XTANDI (Drug) $18,900
  • Oncology (Device) $9,491
  • Axumin (Drug) $7,485
  • ORGOVYX (Drug) $5,019
  • Edge (Device) $3,375
  • ELEKTA MEDICAL LINEAR ACCELERATOR (Device) $139.52
  • PROVENGE (Drug) $129.49
  • Erleada (Drug) $102.79
  • SpaceOAR (Device) $93.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Radiation Oncology Doctors in Maywood